慢性光化性皮炎发病机制及治疗研究进展
摘要
环境因素、自身免疫相关等因素相关。现如今对于其治疗主要包括：预防措施、局部用药及系统用药、光疗等，但
往往难以取得使患者满意的疗效，生物制剂度普利尤单抗的出现给CAD患者的治疗带来了新的思路。
关键词
全文:
PDF参考
[1]HUANG C M, ASAI Y. Chronic actinic dermatitis [J].
CMAJ, 2018, 190(10): E297.
[2]HAWK J L. Chronic actinic dermatitis [J].
Photodermatol Photoimmunol Photomed, 2004, 20(6):
312-4.
[3]SIDIROPOULOS M, DEONIZIO J, MARTINEZ-ESCALA M E, et al. Chronic actinic dermatitis/actinic
reticuloid: a clinicopathologic and immunohistochemical
analysis of 37 cases [J]. Am J Dermatopathol, 2014, 36(11):
875-81.
[4]PAEK S Y, LIM H W. Chronic actinic dermatitis [J].
Dermatol Clin, 2014, 32(3): 355-61, viii-ix.
[5]SOMANI V K. Chronic actinic dermatitis--a study
of clinical features [J]. Indian J Dermatol Venereol Leprol,
2005, 71(6): 409-13.
[6]LUGOVIC MIHIC L, BULAT V, SITUM M, et al.
Allergic hypersensitivity skin reactions following sun exposure
[J]. Coll Antropol, 2008, 32 Suppl 2: 153-7.
[7]BEACH R A, PRATT M D. Chronic actinic
dermatitis: clinical cases, diagnostic workup, and therapeutic
management [J]. J Cutan Med Surg, 2009, 13(3): 121-8.
[8]DAWE R S. Chronic actinic dermatitis in the elderly:
recognition and treatment [J]. Drugs Aging, 2005, 22(3):
201-7.
[9]BLAKELY K M, DRUCKER A M, ROSEN C F.
Drug-Induced Photosensitivity-An Update: Culprit Drugs,
Prevention and Management [J]. Drug Saf, 2019, 42(7): 827-47.
[10]SNYDER M, TURRENTINE J E, CRUZ P
D, JR. Photocontact Dermatitis and Its Clinical Mimics: an
Overview for the Allergist [J]. Clin Rev Allergy Immunol,
2019, 56(1): 32-40.
[11]KIM H J, KIM K H. Increased incidence of chronic
actinic dermatitis in relation to climate changes and air
pollution during the past 15 years in Korea [J]. Photodermatol
Photoimmunol Photomed, 2018, 34(6): 387-92.
[12]HU S C, LAN C E. Tungsten lamp and chronic
actinic dermatitis [J]. Australas J Dermatol, 2017, 58(1): e14-e6.
[13]MOHANIA D, CHANDEL S, KUMAR P, et al.
Ultraviolet Radiations: Skin Defense-Damage Mechanism [J].
Adv Exp Med Biol, 2017, 996: 71-87.
[14]KO D Y, CHOI S H, HA S M, et al. The clinical
severity score of chronic actinic dermatitis correlates with in
vivo photoallergic reactions and the immunologic parameters
related to a shift towards Th2 immunity from the Th2/Th1
balanced status in patients with chronic actinic dermatitis [J].
Photodermatol Photoimmunol Photomed, 2016, 32(4): 199-
206.
[15]ULLRICH S E. Does exposure to UV radiation
induce a shift to a Th-2-like immune reaction? [J].
Photochem Photobiol, 1996, 64(2): 254-8.
[16]MOSMANN T R, COFFMAN R L. TH1 and
TH2 cells: different patterns of lymphokine secretion lead to
different functional properties [J]. Annu Rev Immunol, 1989,
7: 145-73.
[17]ROMAGNANI S. Human TH1 and TH2 subsets:
regulation of differentiation and role in protection and
immunopathology [J]. Int Arch Allergy Immunol, 1992,
98(4): 279-85.
[18]STEINKE J W, BORISH L. Th2 cytokines and
asthma. Interleukin-4: its role in the pathogenesis of asthma,
and targeting it for asthma treatment with interleukin-4
receptor antagonists [J]. Respir Res, 2001, 2(2): 66-70.
[19]SCHMITZ J, OWYANG A, OLDHAM E, et al.
IL-33, an interleukin-1-like cytokine that signals via the
IL-1 receptor-related protein ST2 and induces T helper type
2-associated cytokines [J]. Immunity, 2005, 23(5): 479-90.
[20]BYRNE S N, BEAUGIE C, O’SULLIVAN C,
et al. The immune-modulating cytokine and endogenous
Alarmin interleukin-33 is upregulated in skin exposed to
inflammatory UVB radiation [J]. Am J Pathol, 2011, 179(1):
211-22.
[21]ZIEGLER S F. Thymic stromal lymphopoietin and
allergic disease [J]. J Allergy Clin Immunol, 2012, 130(4):
845-52.
[22]JANG Y, JEONG S H, PARK Y H, et al. UVB
induces HIF-1alpha-dependent TSLP expression via the
JNK and ERK pathways [J]. J Invest Dermatol, 2013, 133(11):
2601-8.
[23]ROELANDTS R. Chronic actinic dermatitis [J]. J
Am Acad Dermatol, 1993, 28(2 Pt 1): 240-9.
[24]FORSYTH E L, MILLARD T P. Diagnosis and
pharmacological treatment of chronic actinic dermatitis in the
elderly: an update [J]. Drugs Aging, 2010, 27(6): 451-6.
[25]SUGA Y, HASHIMOTO Y, MATSUBA S, et al.
Topical tacrolimus for chronic actinic dermatitis [J]. J Am
Acad Dermatol, 2002, 46(2): 321-3.
[26]REITAMO S, RUSTIN M, RUZICKA T, et al.
Efficacy and safety of tacrolimus ointment compared with that
of hydrocortisone butyrate ointment in adult patients with
atopic dermatitis [J]. J Allergy Clin Immunol, 2002, 109(3):
547-55.
[27]DAWE R S, FERGUSON J. Diagnosis and
treatment of chronic actinic dermatitis [J]. Dermatol Ther,
2003, 16(1): 45-51.
[28]LEIGH I M, HAWK J L. Treatment of chronic
actinic dermatitis with azathioprine [J]. Br J Dermatol, 1984,
110(6): 691-5.
[29]PARACHA M M, ZAHOOR H, KHAN A Q,
et al. Efficacy Of Methotrexate Versus Azathioprine In The
Treatment Of Chronic Actinic Dermatitis: A Randomized
Control Trial [J]. J Ayub Med Coll Abbottabad, 2022,
34(Suppl 1)(3): S644-S8.
[30]VERMA L, PRATT M. A case report of
therapeutically challenging chronic actinic dermatitis [J].
SAGE Open Med Case Rep, 2019, 7: 2050313X19845235.
[31]MUNOZ-BELLIDO F J, MORENO E, DAVILA
I. Dupilumab: A Review of Present Indications and Off-Label Uses [J]. J Investig Allergol Clin Immunol, 2022, 32(2):
97-115.
[32]QUATRANO N A, SHVARTSBEYN M,
MEEHAN S A, et al. Chronic actinic dermatitis occurring in
an adult with atopic dermatitis [J]. Dermatol Online J, 2015,
21(12).
[33]RUSSELL S C, DAWE R S, COLLINS P, et
al. The photosensitivity dermatitis and actinic reticuloid
syndrome (chronic actinic dermatitis) occurring in seven
young atopic dermatitis patients [J]. Br J Dermatol, 1998,
138(3): 496-501.
[34]CREAMER D, MCGREGOR J M, HAWK J L.
Chronic actinic dermatitis occurring in young patients with
atopic dermatitis [J]. Br J Dermatol, 1998, 139(6): 1112-3.
[35]张洪卫，杨洋，廖承成.度普利尤单抗注射液治
疗慢性光化性皮炎的临床疗效及安全性[J].临床合理用
药，2023，16（24）：35-8.
[36]WANG T, GONG Y, RONG W, et al. Ultraviolet
A rush hardening for chronic actinic dermatitis: Pilot
treatment outcomes [J]. J Dermatol, 2021, 48(3): 385-8.
[37]HORIO T. Indications and action mechanisms of
phototherapy [J]. J Dermatol Sci, 2000, 23 Suppl 1: S17-21.
Refbacks
- 当前没有refback。
